This is the authors' abstract. We don't add key points for this paper.
One thousand three hundred and twenty adults at risk of occupational exposure to hepatitis B were immunized using genetically engineered surface antigen and their antibody response (anti-HBs IU/l) assessed. Sex was known for all subjects and age for 1120 (range from 17-71 years). Seven hundred and sixty-four subjects were immunized in the local Department of Occupational Health, the remainder mainly by general practitioners. Analysis of 'good responders' (anti-HBs greater than 100 IU/l) according to age and sex showed that increasing age and male sex had independent adverse effects on the likelihood of developing a satisfactory level of antibody to HBsAg. Furthermore even those most likely to respond well (young women), had a 1/5 to 1/6 failure rate to achieve greater than 100 IU/l anti-HBs. Of 63 persons who received a fourth dose of vaccine, 26 developed anti-HBs titres greater than 100 IU/l when tested after 6 months. Subjects who had a low level of anti-HBs following primary immunization were more likely to develop greater than 100 IU/l anti-HBs following a booster dose than were non-responders (less than 10 IU/l).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Westmoreland et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: